5th International Conference on Heart and Cardiovascular Diseases

Heart Failure and Advanced Cardiac Therapies remains an important area in modern cardiovascular medicine due to the growing need for evidence-based diagnosis, advanced therapeutic strategies, precision healthcare, and improved patient outcomes. This session provides a scientific platform for clinicians, researchers, healthcare professionals, and academicians to discuss recent clinical developments, emerging technologies, translational research, and future directions associated with heart failure and advanced cardiac therapies. The session will feature expert presentations, clinical discussions, case-based learning, and interdisciplinary perspectives focused on improving cardiovascular healthcare delivery and advancing global cardiology research.

Key Discussion Areas

• Optimizing and sequencing the four pillars of guideline-directed medical therapy in HFrEF
• How treatment options are evolving for HFpEF as new drug classes emerge
• When to escalate to mechanical circulatory support versus transplant listing
• Remote monitoring and implantable sensors for early decompensation detection
• Managing heart failure with comorbid kidney disease and diabetes
• Navigating palliative and end-of-life care conversations in advanced heart failure

Focus Areas

• HFrEF and HFpEF Management
• Guideline-Directed Medical Therapy Optimization
• Mechanical Circulatory Support and LVADs
• Heart Transplantation
• Remote Monitoring and Heart Failure Devices
• Advanced and Palliative Heart Failure Care
• Heart Failure Biomarkers
• Cardiac Contractility Modulation

Why Attend This Session?

Heart failure specialists, general cardiologists, cardiac surgeons, and advanced practice providers will gain practical frameworks for phenotype-guided therapy selection, guideline-directed medical therapy titration, and up-to-date knowledge on pivotal trial results reshaping cardiomyopathy management.

Clinical Value for Delegates

• A practical roadmap for initiating and optimising quadruple GDMT in HFrEF
• Emerging evidence for HFpEF - the first treatments showing real benefit
• Guidance on selecting and monitoring device therapies including CRT and ICD
• Recognition and management of cardiac amyloidosis in the heart failure clinic

Submit Your Heart Failure Research: Join the global conversation - present your findings to leading heart failure specialists and researchers. Submit Your Abstract →

Related Topics: Cardiomyopathies & Genetics | Cardiovascular Surgery | Electrophysiology & Arrhythmias | Hypertension & Cardiorenal Medicine | AI & Digital Cardiology